Replies to post #27925 on Biotech Values

[DewDiligence]

VRTX is down slightly today, so the market seems to agree with walldiver and me that the new VX-950 data do not change the HCV landscape materially relative to what was already known.

Now if only I could get the market to agree with me on NM283!